Papp K, Reich K, Leonardi CL, Kircik L, Chimenti S, Langley RG, Hu C, Stevens RM, Day RM, Gordon KB, Korman NJ, Griffiths CE (2015) Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)
Dans les soins fonctionnels tels que les srums anti-taches, les crmes unifiantes et les fluides correcteurs le glutathion est associ des filtres UV, des agents hydratants et des ingrdients renforant la barrire cutane pour une formule unique alliant clat, hydratation et protection
Science 355 , eaag2355 (2017)
& Hao, L
Patients should evaluate treatment protocols alongside pricing considerations when selecting their healthcare partners
Always exercise caution and purchase from reputable sources